Modulation Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Data insights

11 April 2025

BridgeBio enters the pan-KRAS game

Meanwhile, Akeso challenges Moderna and BioNTech with an mRNA neoantigen play.

Subscribe to Modulation Therapeutics